Literature DB >> 33530970

Modulation of gastrointestinal bacterial in chronic atrophic gastritis model rats by Chinese and west medicine intervention.

Minghan Huang1, Sihan Li2, Youcheng He1, Cuili Lin1, Yueming Sun1, Mingzhu Li3, Rong Zheng1, Ruoying Xu1, Ping Lin4, Xiao Ke5.   

Abstract

Chronic atrophic gastritis (CAG) is well-known related with multiple pathogenic factors and normally therapies comprised by western or Chinese medicines. The present study was designed to identify the bacterial community characterized by 16S rRNA amplicon sequencing and determine the modulate affection of bacterial composition response western and Chinese medicine Qinghuayin (QHY) as well as antibiotic on model rats. The result shown the overall structure alteration of bacterial appeared under medicine intervened, antibiotic caused a marked depletion in bacterial diversity and richness. The enrichments of Firmicutes (85.1-90.7%) in antibiotic-free converts into Bacteroidetes (30.7-34.6%) in antibiotic-added model rat were demonstrated. Firmicutes as the most dominant phylum in antibiotic-free treatments and significantly decreased till 21.9-68.5% in antibiotic-added treatments. Especially QHY-treated rats showed highest RA of Firmicutes (90.7%) and the amelioration of CAG using QHY attributed by beneficial bacterial enrichment, especially Ruminococcus, Lactobacillus and Bifidobacterium. In addition, alpha and beta diversity analysis also demonstrated the clear dispersion and aggregation that revealed the alteration and steady of bacterial community structures. In summary, QHY has potential application value in the treatment of CAG, which attributed to close relation with the modulatory of internal bacterial communities.

Entities:  

Keywords:  Antibiotic; Chinese medicine; Chronic atrophic gastritis; Dys-bacteriosis; Micro-ecology

Year:  2021        PMID: 33530970     DOI: 10.1186/s12934-021-01525-2

Source DB:  PubMed          Journal:  Microb Cell Fact        ISSN: 1475-2859            Impact factor:   5.328


  30 in total

1.  Qing Hua Chang Yin exerts therapeutic effects against ulcerative colitis through the inhibition of the TLR4/NF-κB pathway.

Authors:  Xiao Ke; Fan Zhou; Youliang Gao; Bingying Xie; Guanghong Hu; Wenyi Fang; Jun Peng; Youqin Chen; Thomas J Sferra
Journal:  Int J Mol Med       Date:  2013-07-29       Impact factor: 4.101

2.  Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium.

Authors:  Sandrine Brugiroux; Markus Beutler; Carina Pfann; Debora Garzetti; Hans-Joachim Ruscheweyh; Diana Ring; Manuel Diehl; Simone Herp; Yvonne Lötscher; Saib Hussain; Boyke Bunk; Rüdiger Pukall; Daniel H Huson; Philipp C Münch; Alice C McHardy; Kathy D McCoy; Andrew J Macpherson; Alexander Loy; Thomas Clavel; David Berry; Bärbel Stecher
Journal:  Nat Microbiol       Date:  2016-11-21       Impact factor: 17.745

3.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.

Authors:  Amandine Everard; Clara Belzer; Lucie Geurts; Janneke P Ouwerkerk; Céline Druart; Laure B Bindels; Yves Guiot; Muriel Derrien; Giulio G Muccioli; Nathalie M Delzenne; Willem M de Vos; Patrice D Cani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

4.  Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication.

Authors:  Esther E Fröhlich; Aitak Farzi; Raphaela Mayerhofer; Florian Reichmann; Angela Jačan; Bernhard Wagner; Erwin Zinser; Natalie Bordag; Christoph Magnes; Eleonore Fröhlich; Karl Kashofer; Gregor Gorkiewicz; Peter Holzer
Journal:  Brain Behav Immun       Date:  2016-02-23       Impact factor: 7.217

5.  Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer.

Authors:  Francisco Aviles-Jimenez; Flor Vazquez-Jimenez; Rafael Medrano-Guzman; Alejandra Mantilla; Javier Torres
Journal:  Sci Rep       Date:  2014-02-26       Impact factor: 4.379

6.  The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis.

Authors:  Yun-Kai Dai; Yun-Zhan Zhang; Dan-Yan Li; Jin-Tong Ye; Ling-Feng Zeng; Qi Wang; Ling Hu
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

7.  Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis.

Authors:  Hung-Yang Chang; Jin-Hua Chen; Jui-Hsing Chang; Hung-Chih Lin; Chien-Yu Lin; Chun-Chih Peng
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

8.  Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population.

Authors:  Chikara Iino; Tadashi Shimoyama; Daisuke Chinda; Tetsu Arai; Daisuke Chiba; Shigeyuki Nakaji; Shinsaku Fukuda
Journal:  Front Immunol       Date:  2018-04-06       Impact factor: 7.561

9.  Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.

Authors:  Shen Li; Jin-Pu Li
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

10.  Confirming the Effects of Qinghuayin against Chronic Atrophic Gastritis and a Preliminary Observation of the Involved Inflammatory Signaling Pathways: An In Vivo Study.

Authors:  Sihan Li; Minghan Huang; Qin Chen; Shunan Li; Xin Wang; Jianlong Lin; Guodong Zhong; Ping Lin; Tetsuya Asakawa
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.